ADT-Related Anxiety Linked to Elevated PSA Renal and Urology News, NY - Nov 14, 2008 ... with elevated serum PSA levels before ADT have a nearly eight times higher risk of developing anxiety. ?We hypothesize that patients with [higher levels ...
Birmingham Prostate Clinic introduces 10-minute PSA test The Birmingham Post, UK - Nov 24, 2008 A raised PSA result is not a diagnosis of prostate cancer but an indication that the patient may be at risk and require further investigations. ...
Age Alone Should Not Deter ADT Use Renal and Urology News, NY - Nov 24, 2008 The men had a median serum PSA level of 21 ng/mL. The median follow-up was 85 months (range 26-206 months). The cumulative incidence of biochemical ...
Lung cancer: Prevention is underfunded Florida Times-Union, FL - Nov 21, 2008 I had none of these risk factors, except I was over 45 years old (I was 46). There is an alarming increase in the population of patients diagnosed with lung ...
More good news about statins Drug Topics Magazine, NJ - Nov 14, 2008 The median LDL decline was 27.5%, and the median PSA decline was 4.1%. The caveats: The effect of statins on the risk of prostate cancer was not determined ...
Source: Google News
Recent News and Articles on the Keywords: 0.34 + patient + 3,990 Related to the article below (Last Update: 8/7/2008)
Allos Therapeutics Reports 2008 Second Quarter Results MarketWatch - Aug 5, 2008 In July 2008, the Company initiated patient enrollment in a Phase 2, open-label, single-arm, multi-center study of PDX in patients with advanced or ...ALTH
Medarex Announces 2008 Second Quarter Financial Results Earthtimes (press release), UK - Aug 5, 2008 ... slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of antibody products in patients, ...MEDX
Ethnicity and quality of antipsychotic prescribing among in ... British Journal of Psychiatry (subscription), UK - Jul 31, 2008 Median dose of antipsychotic (% of licensed dose) was 58.3% for White and 50.0% for Black patients (adjusted effect size=0.14, 95% CI ?0.34 to 0.63). ...
Complex intervention improved depressive symptoms HemOncToday, NJ - Jul 24, 2008 The mean reduction in the study arm compared with the control arm was 0.34 (95% CI, 0.13-0.55). The researchers indicated that depression scores in the ...
Intervention Delivered By Nurses Can Help Combat Depression In ... Medical News Today (press release), UK - Jul 23, 2008 Sharpe and colleagues found that patients who received DCPC had a lower depression level - by 0.34 on the scale - than those who did not receive DCPC. ...
Low Salt Diet No Help for Asthma Control MedPage Today, NJ - Jul 15, 2008 However, the researchers noted that they were unable to exclude the possibility that a longer intervention period or different patient subgroups may have ...
Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells - B Jaar, C Baillou, B Viron, C Michel, F Mignon, A … - Nephrology Dialysis Transplantation, 1993 - ERA-EDTA ... On the other hand, in patient n? 7, who had peritonitis 3 weeks after the beginning
of rHuEpo therapy, only a delayed response was ... 9.63 0.34... M6 4900 5410 3990...
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium … - S Rijal, F Chappuis, R Singh, PA Bovier, P Acharya … - Transactions of the Royal Society of Tropical Medicine and …, 2003 - Elsevier ... White blood cells (/mm 3) 4030 (1310) 3990 4360 ... Cough 11 (10.0) 2 (18.2) 0.34 Abdominal
pain 23 (20.9) 3 (13.0) 0.58 ... In-patient (Group A) 84 (76.4) 9 (10.7) ...
Minimal Access Surgical Techniques in Coronary Artery Bypass Grafting for Triple-Vessel Disease - PJ Lin, CH Chang, JJ Chu, HP Liu, FC Tsai, FC Lin, … - The Annals of Thoracic Surgery, 1998 - Soc Thorac Surgeons ... b 2 (13) LVEF a 0.57 0.16 (0.34?0.83 ... for complete revascularization (four distal
anastomoses in each patient). ... Telephone: (212) 633-3950; Fax: (212) 633-3990. ...
Localization of branchio-oto-renal (BOR) syndrome to a 3 Mb region of chromosome 8q - Y Wang, K Treat, RJ Schroer, JE O?Brien, RE … - Am J Med Genet, 1994 - doi.wiley.com ... 0.07 0.40 0.34 0.22 -0.52 -1.42 -0.04 0.50 -0.14 -0.00 0.01 ... crossover events (Figure
1). Two males (3990 and 4844 ... the BOR syndrome was based on a patient with a ...
Determinants of the apnea index in a sleep center population - Y Tashkandi, MS Badr, JA Rowley - Sleep and Breathing, 2005 - Springer ... Sleep Medicine, Harper University Hospital, 3990 John R ... disease severity, we divided
the patient population into ... and age (correlation coefficient 0.04, p=0.34). ...
Source: Google Scholar
TURP patients with intermediate PSA should be considered high-risk
Researchers at Fox Chase Cancer Center recommend more aggressive treatment for men whose prostate cancers occurred after transurethral resection of the prostate ( TURP ) and whose PSA level is considered intermediate.
When planning for treatment, radiation oncologists evaluate the pretreatment PSA ( prostate specific antigen ) because it is a strong predictor of the patient's outcome following radiotherapy. The pretreatment PSA is used to determine the appropriate radiotherapy dose and whether androgen deprivation therapy should be given. Doctors say evaluating a patient's PSA level after surgical removal of some prostate tissue with a TURP, which is often done for men who have an enlarged prostate with significant urinary symptoms unrelated to prostate cancer, is not an accurate picture of disease progression.
" PSA is secreted from both normal and cancerous tissue," explained lead author David J. D'Ambrosio, at Fox Chase Cancer Center. " Patients who have had a TURP prior to their prostate cancer treatment may have lower pretreatment PSA levels because there is less prostate tissue remaining. This can mislead physicians regarding the extent of disease." D'Ambrosio said that men with a PSA level of 10 to 20 likely would have had a PSA of greater than 20 if they did not have surgery to remove their some of their prostate, and therefore would have received more aggressive treatment.
The study evaluated 1,287 men with low to intermediate risk with a similar stage of disease. All had a pretreatment PSA of less than 20 and received 3D conformal radiotherapy without hormone ( androgen deprivation ) therapy. Of these, 143 men had a prior TURP. The median pretreatment PSA was 7.3 ( range: 0.1-19.9 ). The number of men with PSA greater than 10 was 362 ( 28 percent ).
Prior TURP was the common denominator among patients who had a pretreatment PSA of 10 to 19.9 who later recurred. There was no strong relationship between the surgery and recurrence for patients with a pretreatment PSA of less than 10.
As D'Ambrosio explained, " Patients with a pretreatment PSA of 10 to 19.9 were more likely to recur if they had prior TURP. This group also had other pretreatment indicators that normally would not have indicated a high-risk of recurrence." ( Gleason Score of 2-6 vs. 7, Stage T1c vs. T2 ).
" A history of a TURP reduced the accuracy of PSA as a pretreatment indicator for recurrence. The treatment plan for men who have an intermediate PSA who have also had TURP may include a recommendation of androgen deprivation."
Comment by Elizabeth G. Nabel M.D.
